Education
About Us
Working with TipRanks
Follow Us
XEML - ETF AI Analysis
Top Page
Xtrackers Europe Market Leaders ETF (XEML)
Rating:68Neutral
Price Target:―
Positive Factors
Strong Geographic Diversification
The ETF invests across multiple European countries, reducing reliance on any single economy.
Balanced Sector Exposure
The fund is well-diversified across key sectors like Industrials, Health Care, and Consumer Defensive, which can provide stability.
Reasonable Expense Ratio
With a competitive expense ratio, the ETF offers a cost-effective way to invest in European market leaders.
Negative Factors
Overweight in France and Switzerland
A significant portion of the portfolio is concentrated in France and Switzerland, increasing exposure to these economies.
Underwhelming Year-to-Date Performance
The ETF has shown minimal growth so far this year, which may concern investors seeking stronger returns.
Limited Exposure to Emerging Markets
The fund focuses exclusively on developed European markets, missing out on potential growth opportunities in emerging economies.
XEML vs. SPDR S&P 500 ETF (SPY)
AUM5.41M
RegionEurope
Expense Ratio0.35%
Beta0.45
IssuerXtrackers
Inception DateDec 23, 2025
Dividend YieldN/A
Asset ClassEquity
Index TrackedSTOXX Europe Total Market Leaders Index - USD - Benchmark TR Net
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume25
30 Day Avg. Volume489
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
29.03Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering40
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
XEML Summary
The Xtrackers Europe Market Leaders ETF (XEML) is a fund that lets you invest in 40 of the largest and most influential companies across Europe. It tracks the STOXX Europe Total Market Leaders Index and includes well-known companies like Novartis and LVMH. This ETF focuses on a mix of industries, such as healthcare, consumer goods, and industrials, offering a diversified way to invest in Europe’s economic leaders. It’s a good option for those looking for growth and stability from established companies. However, since it’s tied to European markets, its performance can be affected by economic changes in the region.
How much will it cost me?The Xtrackers Europe Market Leaders ETF (XEML) has an expense ratio of 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it focuses on a niche index of Europe's top 40 companies, requiring specialized tracking.
What would affect this ETF?The XEML ETF, focused on Europe's leading companies, could benefit from positive economic growth in developed Europe, increased consumer spending, and advancements in healthcare and technology sectors, which are heavily represented in its holdings. However, it may face challenges from rising interest rates, regulatory changes in Europe, or economic slowdowns that could impact industrial and consumer-focused companies. Global geopolitical tensions or trade disruptions could also negatively affect its performance.
XEML Top 10 Holdings
XEML leans heavily into Europe’s health care and industrial champions, with names like ASML and ABB doing much of the heavy lifting as their shares have been steadily rising. Drugmakers Roche and Novartis add defensive strength, though their momentum looks more steady than spectacular. L’Oréal has been a quiet positive, even if its rich valuation hints it could be running a bit hot. On the softer side, Schneider Electric and Safran have shown more mixed, sometimes lagging moves, reminding investors that this Europe-focused fund is diversified but not immune to sector mood swings.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 5.50% | $300.44K | €475.49B | 74.46% | 76 Outperform | |
| ABB Ltd | 5.05% | $275.62K | kr1.51T | 33.87% | 78 Outperform | |
| Novartis AG | 5.03% | $274.75K | CHF242.43B | 28.84% | 80 Outperform | |
| GlaxoSmithKline | 5.02% | $274.12K | £91.50B | 54.86% | 77 Outperform | |
| Deutsche Telekom | 5.01% | $273.36K | €158.31B | -5.01% | 67 Neutral | |
| SAFRAN SA | 4.89% | $267.03K | €142.86B | 41.01% | 67 Neutral | |
| Roche Holding AG | 4.86% | $265.41K | CHF294.84B | 46.01% | 73 Outperform | |
| Vinci SA | 4.82% | $262.90K | €76.89B | 28.74% | 76 Outperform | |
| Schneider Electric | 4.51% | $246.34K | €147.11B | 0.62% | 62 Neutral | |
| L'Oreal | 4.44% | $242.56K | €210.07B | 17.03% | 71 Outperform |
XEML Technical Analysis
Positive
―
Price Trends
Market Momentum
0.45
Negative
69.18
Neutral
92.73
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XEML, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 26.57, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.45 indicates Negative momentum. The RSI at 69.18 is Neutral, neither overbought nor oversold. The STOCH value of 92.73 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XEML.
XEML Peer Comparison
Comparison Results
Performance Comparison
XEML
Xtrackers Europe Market Leaders ETF
27.37
2.12
8.40%
VGK
Vanguard FTSE Europe ETF
―
―
―
EUDG
WisdomTree Europe Quality Dividend Growth Fund
―
―
―
FLEU
Franklin FTSE Eurozone ETF
―
―
―
DBEZ
Xtrackers MSCI Eurozone Hedged Equity ETF
―
―
―
PTEU
Pacer Trendpilot European Index ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents